Leader Pharmaceuticals Biotechnology (00399) plans to discount approximately 17.84% of the rights issue, with a maximum net proceeds of approximately HK$35.52 million.

Wise Finance and Economics App news, Leading Biomedical Technology (00399) issued an announcement on May 29, 2025, the company intends to issue a maximum of 206.4 million shares, accounting for approximately 10.17% of the enlarged issued share capital of the company through the issuance and distribution of all new shares. The subscription price per share of 0.175 Hong Kong dollars is approximately 17.84% discount to the closing price of 0.213 Hong Kong dollars per share on May 29th.